涉嫌误导性陈述，深圳企业亚辉龙被证监会立案调查

Group 1 - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. (Yahui Long) for allegedly misleading statements in their announcement regarding a strategic cooperation framework agreement [1][2] - Yahui Long received a notice from the CSRC on February 6, 2026, indicating that the company is under investigation for violations of information disclosure laws [1] - The strategic cooperation agreement signed with Shenzhen Brain Machine Star Chain Technology Co., Ltd. is described as an intention-based agreement without specific financial commitments, which does not require board or shareholder approval [1] Group 2 - The Shanghai Stock Exchange (SSE) has sent an inquiry letter to Yahui Long and issued a regulatory warning to the company and its responsible personnel, emphasizing the need for accurate and complete information disclosure, especially regarding the hot market concept of "brain-machine interfaces" [2] - The SSE criticized Yahui Long for inconsistent statements regarding the technical path of the cooperation partner and for failing to adequately disclose risks related to cooperation feasibility and uncertainties, which are of significant concern to investors [2] - The SSE determined that Yahui Long's actions violated relevant regulations of the Shanghai Stock Exchange's listing rules and self-regulatory guidelines, holding the then Secretary of the Board, Wang Mingyang, accountable for the company's disclosure violations [2]